Codexis, INC.
SEC CIK 1200375 · CDXS · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Parker H Stewart | Director | filed 2022 - 2026 |
| Smith David V | Director | filed 2016 - 2026 |
| Singhvi Rahul | Director | filed 2022 - 2026 |
| Dilly Stephen George | Director · See Remarks | filed 2020 - 2026 |
| Collins Cynthia | Director | filed 2025 - 2026 |
| Richards Christos | Director | filed 2025 - 2026 |
| Martinborough Esther | Director | filed 2021 - 2026 |
| De Vre Raymond | Director | filed 2024 - 2026 |
| Moore Alison | Director · President and CEO | filed 2020 - 2026 |
| Wolf Dennis P | Director | filed 2010 - 2025 |
| Dorgan Byron L | Director | filed 2011 - 2024 |
| Aaker Jennifer | Director | filed 2020 - 2023 |
| Nicols John J | Director · President and CEO | filed 2012 - 2023 |
| Yang Patrick Y | Director | filed 2014 - 2022 |
| Kelley Bernard J | Director | filed 2010 - 2021 |
| Baruch Thomas R | Director | filed 2010 - 2020 |
| Glaub Kathleen Sereda | Director | filed 2014 - 2019 |
| Cheng Pam P. | Director | filed 2014 - 2019 |
| Cmea Ventures Life Sciences 2000 LP | Director | filed 2010 - 2014 |
| Karsner Alexander | Director | filed 2010 - 2014 |
| Shaw Alan | Director · President and CEO | filed 2010 - 2011 |
| Mizutani Pedro Isamu | Director | filed 2011 - 2011 |
| Maxygen INC | Director | filed 2010 - 2010 |
| Pasternack Bruce A | Director | filed 2010 - 2010 |
| Sulat James R | Director | filed 2010 - 2010 |
| Wong Mun Yew | Director | filed 2010 - 2010 |
| Streng Chris | Director | filed 2010 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Erbez Georgia | See Remarks | filed 2024 - 2026 |
| Lutz Stefan | Chief Scientific Officer | filed 2025 - 2026 |
| Norrett Kevin | Chief Operating Officer | filed 2022 - 2025 |
| Ryali Sriram | Chief Financial Officer | filed 2023 - 2024 |
| Fitzgerald Margaret Nell | See remarks | filed 2022 - 2024 |
| Taylor Dean Ross JR | SVP, Chief Scientific Officer | filed 2019 - 2023 |
| Lalonde James | SVP, R&D | filed 2014 - 2019 |
| Sangster Gordon | SVP & Chief Financial Officer | filed 2014 - 2019 |
| Aldridge Michael D. | See Remarks | filed 2016 - 2018 |
| Sheehy Douglas T. | See Remarks | filed 2010 - 2016 |
| O'Toole David D | SVP & Chief Financial Officer | filed 2012 - 2013 |
| Tobin Matthew | SVP, Research & Development | filed 2012 - 2013 |
| Anton David L. | SVP, Research and Development | filed 2010 - 2013 |
| Seufer-Wasserthal Peter | SVP, Pharmaceuticals | filed 2013 - 2013 |
| Ho Mark | Principal Accounting Officer | filed 2012 - 2012 |
| Strumph Peter M | Interim President and CEO | filed 2012 - 2012 |
| Dowd Brian Paul | Interim CFO | filed 2012 - 2012 |
| Sarret Joseph J. | SVP and CBO | filed 2010 - 2012 |
| Lawson Robert J | SVP and CFO | filed 2010 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.